These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22022826)

  • 1. A review of candidate urinary biomarkers for autism spectrum disorder.
    Wang L; Angley MT; Gerber JP; Sorich MJ
    Biomarkers; 2011 Nov; 16(7):537-52. PubMed ID: 22022826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.
    Kern JK; Geier DA; Adams JB; Geier MR
    Biometals; 2010 Dec; 23(6):1043-51. PubMed ID: 20532957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
    Wang L; Angley MT; Gerber JP; Young RL; Abarno DV; McKinnon RA; Sorich MJ
    Biomarkers; 2009 Dec; 14(8):596-603. PubMed ID: 19697973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.
    Nataf R; Skorupka C; Amet L; Lam A; Springbett A; Lathe R
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):99-108. PubMed ID: 16782144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
    Wang L; Angley MT; Sorich MJ; Young RL; McKinnon RA; Gerber JP
    Autism Res; 2010 Oct; 3(5):268-72. PubMed ID: 20589913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders.
    Geier DA; Kern JK; Geier MR
    J Toxicol Environ Health A; 2009; 72(24):1585-91. PubMed ID: 20077233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are urinary porphyrins a valid diagnostic biomarker of autism spectrum disorder?
    Shandley K; Austin DW; Bhowmik JL
    Autism Res; 2014 Oct; 7(5):535-42. PubMed ID: 24756868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary p-cresol in autism spectrum disorder.
    Persico AM; Napolioni V
    Neurotoxicol Teratol; 2013; 36():82-90. PubMed ID: 22975621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyrinuria in Korean children with autism: correlation with oxidative stress.
    Youn SI; Jin SH; Kim SH; Lim S
    J Toxicol Environ Health A; 2010; 73(10):701-10. PubMed ID: 20391113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of environmental toxicity and susceptibility in autism.
    Geier DA; Kern JK; Garver CR; Adams JB; Audhya T; Nataf R; Geier MR
    J Neurol Sci; 2009 May; 280(1-2):101-8. PubMed ID: 18817931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins.
    Kern JK; Geier DA; Adams JB; Mehta JA; Grannemann BD; Geier MR
    Pediatr Int; 2011 Apr; 53(2):147-53. PubMed ID: 20626635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary p-cresol is elevated in small children with severe autism spectrum disorder.
    Altieri L; Neri C; Sacco R; Curatolo P; Benvenuto A; Muratori F; Santocchi E; Bravaccio C; Lenti C; Saccani M; Rigardetto R; Gandione M; Urbani A; Persico AM
    Biomarkers; 2011 May; 16(3):252-60. PubMed ID: 21329489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.
    Heyer NJ; Echeverria D; Woods JS
    Autism Res; 2012 Apr; 5(2):84-92. PubMed ID: 22298513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders.
    Geier DA; Geier MR
    J Toxicol Environ Health A; 2007 Oct; 70(20):1723-30. PubMed ID: 17885929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.
    Bradstreet JJ; Smith S; Baral M; Rossignol DA
    Altern Med Rev; 2010 Apr; 15(1):15-32. PubMed ID: 20359266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.
    Bull G; Shattock P; Whiteley P; Anderson R; Groundwater PW; Lough JW; Lees G
    Med Sci Monit; 2003 Oct; 9(10):CR422-5. PubMed ID: 14523330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.
    Mavel S; Nadal-Desbarats L; Blasco H; Bonnet-Brilhault F; Barthélémy C; Montigny F; Sarda P; Laumonnier F; Vourc'h P; Andres CR; Emond P
    Talanta; 2013 Sep; 114():95-102. PubMed ID: 23953447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the influence of researcher-partner involvement on the process and outcomes of participatory research in autism spectrum disorder and neurodevelopmental disorders: a scoping review.
    Jivraj J; Sacrey LA; Newton A; Nicholas D; Zwaigenbaum L
    Autism; 2014 Oct; 18(7):782-93. PubMed ID: 24989447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism spectrum disorders and inborn errors of metabolism: an update.
    Ghaziuddin M; Al-Owain M
    Pediatr Neurol; 2013 Oct; 49(4):232-6. PubMed ID: 23921282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders.
    Wang L; Conlon MA; Christophersen CT; Sorich MJ; Angley MT
    Biomark Med; 2014; 8(3):331-44. PubMed ID: 24712423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.